How to legally get Wegovy online in New York

In a world where healthcare accessibility continues to evolve, telehealth has emerged as a convenient option for many treatments, including weight loss medication prescriptions. If you’ve been wondering whether you can legally access medications like Wegovy, Ozempic, or Mounjaro through telehealth services, the answer is generally yes—but with some important state-specific considerations.

The Federal Telehealth Landscape for Weight Loss Medications

Good news: On the federal level, GLP-1 medications like Wegovy (semaglutide) and Mounjaro/Zepbound (tirzepatide) can be legally prescribed via telehealth. Since these medications are not controlled substances, they aren’t subject to the DEA’s Ryan Haight Act, which would otherwise require an in-person examination before prescribing.

What this means for patients: A licensed healthcare provider can evaluate you through a virtual visit and, if appropriate, electronically send a prescription to your local pharmacy—all without you needing to step foot in a physical office.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Understanding State-by-State Telehealth Rules

While federal law permits telehealth prescribing of GLP-1 medications, individual states have their own regulations that can affect how these medications are prescribed. Here’s a breakdown of key differences:

States with No In-Person Requirements

These states fully embrace telehealth for weight loss medications, allowing providers to prescribe after a thorough virtual consultation:

• California – Pioneers in telehealth, with no special restrictions for weight loss prescriptions
• Connecticut – Requires behavioral counseling and lifestyle modifications alongside medications
• Florida – Allows telehealth prescribing but requires BMI ≥30 and follow-up visits every 3 months
• Illinois – No special weight-loss prescribing rules beyond standard of care
• New York – Has embraced telehealth with no unique limits on GLP-1 prescribing
• Washington – Fully permits telehealth with no in-person requirements

States Requiring Initial In-Person Visits

These states still allow telehealth for ongoing care but typically require an initial face-to-face evaluation:

• Arkansas – One of the more restrictive states, requiring first examination to be in-person
• Delaware – Requires initial in-person physical exam before telehealth prescribing
• Georgia – State obesity Rx policy mandates initial in-person evaluation
• Mississippi – Requires seeing the patient once in-person for weight management therapy
• New Jersey – Requires comprehensive in-person exam and lab work initially
• North Dakota – Expects hands-on initial evaluation for weight-loss treatment
• South Carolina – Must examine patient in person first per state requirements
• Texas – In-person exam generally expected prior to teleRx for weight loss
• Utah – Initial in-person exam encouraged per state guidelines
• Virginia – Must perform physical exam and labs initially for weight management

Provider Types and Prescribing Authority

Another important consideration is understanding who can legally prescribe these medications via telehealth:

• Physicians (MDs/DOs) can prescribe GLP-1 medications via telehealth in all states (as long as they’re licensed in your state).
• Nurse Practitioners (NPs) can prescribe in every state, but their level of independence varies:
• States with full independent practice: California, Connecticut, New York, North Dakota, Utah, Virginia, Washington
• States requiring collaboration with physicians: Arkansas, Delaware, Florida, Georgia, Illinois, Mississippi, New Jersey, Pennsylvania, South Carolina, Texas

At Klarity Health, we ensure all our providers are appropriately licensed and credentialed in accordance with your state’s regulations, so you can feel confident in the legitimacy of your prescriber.

What to Expect During a Telehealth Consultation

A legitimate telehealth consultation for weight loss medications typically includes:

1. Comprehensive health screening – You’ll complete a detailed medical questionnaire about your health history, current medications, and weight management goals
2. Video consultation – A face-to-face virtual meeting with a healthcare provider who will evaluate your eligibility
3. Eligibility assessment – Providers will verify you meet clinical criteria (typically BMI ≥30, or ≥27 with weight-related conditions)
4. Medication education – Discussion of potential benefits, side effects, and proper usage
5. Prescription and follow-up – If appropriate, electronic prescription to your pharmacy and scheduling regular check-ins

Common Misconceptions About Telehealth Weight Loss Medications

Myth: ‘Anyone can get these medications online for quick weight loss.’Reality: Legitimate telehealth providers conduct thorough screenings. You generally need a clinical diagnosis of obesity or an appropriate medical need.

Myth: ‘These are just ‘diet pills’ that can be casually prescribed.’Reality: GLP-1 medications require monitoring for side effects and work gradually. Reputable providers will set realistic expectations and discontinue therapy if it’s not safe or effective.

Myth: ‘Telehealth prescriptions aren’t as legitimate as in-person ones.’Reality: When obtained through proper channels, telehealth prescriptions are just as valid as those from in-person visits.

Red Flags to Watch For

Be cautious of any telehealth provider that:

• Guarantees a prescription without a thorough evaluation
• Sells ‘compounded’ versions of semaglutide (FDA banned most compounded Wegovy copies in 2025)
• Doesn’t schedule follow-ups or monitor your progress
• Lacks transparency about provider credentials or state licensing
• Skips discussions about risks and alternatives
• Has no physical address or clinic affiliation

How Klarity Health Can Help

At Klarity Health, we understand navigating telehealth regulations for weight loss medications can be confusing. Our platform connects you with licensed providers who understand your state’s specific requirements. We offer:

• Transparent process – Clear information about what to expect during your consultation
• Properly licensed providers – All our clinicians are licensed in your state and follow appropriate prescribing protocols
• Comprehensive care – Beyond medication, we focus on sustainable weight management strategies
• Ongoing support – Regular follow-ups to monitor your progress and adjust treatment as needed
• Insurance options – We accept both insurance and cash payment to maximize accessibility

The Future of Telehealth and Weight Loss Treatment

The landscape for telehealth prescribing continues to evolve. While the DEA’s COVID-era flexibilities for controlled substances are currently extended through December 31, 2025, GLP-1 medications aren’t directly affected by these rules since they aren’t controlled substances.

What this means for patients: Access to weight loss medications via telehealth is likely to remain available and potentially improve as regulations continue to modernize across states.

Taking the Next Step

If you’re considering weight loss medication through telehealth, start by researching your state’s specific requirements. A consultation with a qualified healthcare provider through a reputable platform like Klarity Health can help determine if you’re a good candidate for GLP-1 medications and guide you through the process in accordance with your state’s regulations.

Remember that these medications work best as part of a comprehensive approach to weight management that includes healthy eating, regular physical activity, and behavioral modifications.

Ready to explore your options? Visit Klarity Health today to connect with a licensed provider who can help you navigate your weight loss journey safely and effectively.

📅 RESEARCH CURRENCY STATEMENT
Verified as of: December 17, 2025
DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025 (www.axios.com) (www.dea.gov). Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.
States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of Dec 2025)
**Sources newer than

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid